{"id":85104,"date":"2021-03-25T02:14:05","date_gmt":"2021-03-25T05:14:05","guid":{"rendered":"https:\/\/iclos.global\/eng\/?page_id=85104"},"modified":"2021-06-03T02:54:26","modified_gmt":"2021-06-03T05:54:26","slug":"research-development","status":"publish","type":"page","link":"https:\/\/iclos.global\/eng\/research-development\/","title":{"rendered":"R+D"},"content":{"rendered":"

[vc_row unlock_row_content=\u00bbyes\u00bb row_height_percent=\u00bb1″ override_padding=\u00bbyes\u00bb h_padding=\u00bb0″ top_padding=\u00bb0″ bottom_padding=\u00bb0″ back_color=\u00bbcolor-877404″ back_image=\u00bb84490″ back_repeat=\u00bbrepeat-y\u00bb back_position=\u00bbcenter center\u00bb overlay_alpha=\u00bb50″ equal_height=\u00bbyes\u00bb gutter_size=\u00bb0″ column_width_percent=\u00bb0″ shift_y=\u00bb0″ z_index=\u00bb0″ medium_visibility=\u00bbyes\u00bb mobile_visibility=\u00bbyes\u00bb css=\u00bb.vc_custom_1616373523038{margin-top: 0px !important;margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}\u00bb back_size=\u00bb100%\u00bb][vc_column column_width_percent=\u00bb100″ position_vertical=\u00bbmiddle\u00bb align_horizontal=\u00bbalign_center\u00bb gutter_size=\u00bb3″ style=\u00bbdark\u00bb overlay_alpha=\u00bb50″ shift_x=\u00bb0″ shift_y=\u00bb0″ shift_y_down=\u00bb0″ z_index=\u00bb0″ medium_width=\u00bb0″ mobile_width=\u00bb0″ width=\u00bb1\/1″][\/vc_column][\/vc_row][vc_row unlock_row_content=\u00bbyes\u00bb row_height_percent=\u00bb0″ override_padding=\u00bbyes\u00bb h_padding=\u00bb7″ top_padding=\u00bb2″ bottom_padding=\u00bb2″ overlay_alpha=\u00bb50″ gutter_size=\u00bb4″ column_width_percent=\u00bb85″ shift_y=\u00bb0″ z_index=\u00bb0″ css=\u00bb.vc_custom_1617426773550{margin-top: 50px !important;margin-bottom: 60px !important;}\u00bb][vc_column column_width_percent=\u00bb100″ gutter_size=\u00bb3″ overlay_alpha=\u00bb50″ shift_x=\u00bb0″ shift_y=\u00bb0″ shift_y_down=\u00bb0″ z_index=\u00bb0″ medium_width=\u00bb0″ mobile_width=\u00bb0″ width=\u00bb1\/2″][vc_custom_heading heading_semantic=\u00bbh4″ text_font=\u00bbfont-195522″ text_size=\u00bbh1″ text_weight=\u00bb400″ text_color=\u00bbcolor-459661″ el_class=\u00bbtitulo-link-azul\u00bb]Iclos Uruguay<\/a>[\/vc_custom_heading][vc_single_image media=\u00bb85177″ media_width_percent=\u00bb100″][vc_column_text text_lead=\u00bbyes\u00bb]Iclos Uruguay (originally known as Clausen) was founded in the early 20th century with a strong focus on the manufacture of chemicals. In 2007, the company’s current production plant was opened, becoming the first biological product plant in the country and the only one approved by the European Medicines Agency (EMA) in Uruguay. Now-a-days, Iclos Uruguay has a high-tech pharmaceutical plant in over 6,500 square meters, comprising two production plants following the most demanding international standards.[\/vc_column_text][vc_column_text text_lead=\u00bbyes\u00bb el_class=\u00bbtitulo-link-azul achico-margtop\u00bb][+] Iclos Uruguay<\/a>[\/vc_column_text][\/vc_column][vc_column column_width_percent=\u00bb100″ gutter_size=\u00bb3″ overlay_alpha=\u00bb50″ shift_x=\u00bb0″ shift_y=\u00bb0″ shift_y_down=\u00bb0″ z_index=\u00bb0″ medium_width=\u00bb0″ mobile_width=\u00bb0″ width=\u00bb1\/2″][vc_custom_heading heading_semantic=\u00bbh4″ text_font=\u00bbfont-195522″ text_size=\u00bbh1″ text_weight=\u00bb400″ text_color=\u00bbcolor-459661″ el_class=\u00bbtitulo-link-azul\u00bb]Gema<\/a>[\/vc_custom_heading][vc_single_image media=\u00bb85180″ media_width_percent=\u00bb100″][vc_column_text text_lead=\u00bbyes\u00bb]Gemabiotech is a member of AMEGA Biotech, the biopharmaceutical platform integrating development and production operations, designing all processes, from clone selection to purified protein production, and finished products formulation.
\nAMEGA has a team specialized in the development of biosimilars. The company has all necessary facilities, from molecular biology, cell culture and downstream process development, to a pre-clinical studies department, where more than 15 bacterial and mammalian processes are developed.[\/vc_column_text][vc_column_text text_lead=\u00bbyes\u00bb el_class=\u00bbtitulo-link-azul achico-margtop\u00bb][+] Gema<\/a>[\/vc_column_text][\/vc_column][\/vc_row][vc_row unlock_row_content=\u00bbyes\u00bb row_height_percent=\u00bb0″ override_padding=\u00bbyes\u00bb h_padding=\u00bb0″ top_padding=\u00bb0″ bottom_padding=\u00bb0″ overlay_alpha=\u00bb100″ gutter_size=\u00bb0″ style=\u00bbinherited\u00bb][\/vc_row][vc_row unlock_row_content=\u00bbyes\u00bb row_height_percent=\u00bb0″ override_padding=\u00bbyes\u00bb h_padding=\u00bb0″ top_padding=\u00bb0″ bottom_padding=\u00bb0″ overlay_alpha=\u00bb50″ equal_height=\u00bbyes\u00bb gutter_size=\u00bb0″ shift_y=\u00bb0″][\/vc_row][vc_row unlock_row_content=\u00bbyes\u00bb row_height_percent=\u00bb0″ overlay_alpha=\u00bb50″ gutter_size=\u00bb3″ column_width_percent=\u00bb100″ shift_y=\u00bb0″ z_index=\u00bb0″ el_class=\u00bbdestructor-total mg-iclos\u00bb][vc_column width=\u00bb1\/1″][uncode_slider slider_type=\u00bbfade\u00bb slider_interval=\u00bb10000″ slider_navspeed=\u00bb1000″ slider_loop=\u00bbyes\u00bb slider_hide_dots=\u00bbyes\u00bb][vc_row_inner row_inner_height_percent=\u00bb0″ force_width_grid=\u00bbyes\u00bb overlay_alpha=\u00bb50″ gutter_size=\u00bb3″ shift_y=\u00bb0″ z_index=\u00bb0″ el_class=\u00bbdestructor-total mg-iclos\u00bb][vc_column_inner column_width_percent=\u00bb100″ gutter_size=\u00bb3″ overlay_alpha=\u00bb50″ shift_x=\u00bb0″ shift_y=\u00bb0″ shift_y_down=\u00bb0″ z_index=\u00bb0″ desktop_visibility=\u00bbyes\u00bb medium_width=\u00bb0″ mobile_width=\u00bb0″ width=\u00bb1\/3″][vc_single_image media=\u00bb85984″ media_width_percent=\u00bb100″][\/vc_column_inner][vc_column_inner column_width_percent=\u00bb100″ gutter_size=\u00bb3″ overlay_alpha=\u00bb50″ shift_x=\u00bb0″ shift_y=\u00bb0″ shift_y_down=\u00bb0″ z_index=\u00bb0″ medium_width=\u00bb0″ mobile_width=\u00bb0″ width=\u00bb1\/3″ el_class=\u00bbpg-iclos\u00bb][vc_custom_heading heading_semantic=\u00bbh3″ text_font=\u00bbfont-195522″ text_size=\u00bbh1″ text_weight=\u00bb700″ text_color=\u00bbcolor-459661″ separator=\u00bbyes\u00bb separator_color=\u00bbyes\u00bb]Research & Development[\/vc_custom_heading][vc_column_text text_lead=\u00bbyes\u00bb css_animation=\u00bbright-t-left\u00bb animation_speed=\u00bb900″ animation_delay=\u00bb200″]Iclos Uruguay has a Research and Development Department of segregated oral solid drugs. Developments in this area include immunosuppressants, oncological drugs (for the treatment of solid and hemo-oncological tumors), and enzyme inhibitors for autoimmune diseases such as rheumatoid arthritis.[\/vc_column_text][\/vc_column_inner][vc_column_inner column_width_percent=\u00bb100″ gutter_size=\u00bb3″ back_image=\u00bb85984″ overlay_alpha=\u00bb50″ shift_x=\u00bb0″ shift_y=\u00bb0″ shift_y_down=\u00bb0″ z_index=\u00bb0″ medium_visibility=\u00bbyes\u00bb medium_width=\u00bb0″ mobile_visibility=\u00bbyes\u00bb mobile_width=\u00bb0″ width=\u00bb1\/3″ el_class=\u00bbbloque-deco\u00bb][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_inner_height_percent=\u00bb0″ force_width_grid=\u00bbyes\u00bb overlay_alpha=\u00bb50″ gutter_size=\u00bb3″ shift_y=\u00bb0″ z_index=\u00bb0″ el_class=\u00bbdestructor-total mg-iclos\u00bb][vc_column_inner column_width_percent=\u00bb100″ gutter_size=\u00bb3″ overlay_alpha=\u00bb50″ shift_x=\u00bb0″ shift_y=\u00bb0″ shift_y_down=\u00bb0″ z_index=\u00bb0″ desktop_visibility=\u00bbyes\u00bb medium_width=\u00bb0″ mobile_width=\u00bb0″ width=\u00bb1\/3″][vc_single_image media=\u00bb85985″ media_width_percent=\u00bb100″][\/vc_column_inner][vc_column_inner column_width_percent=\u00bb100″ gutter_size=\u00bb3″ overlay_alpha=\u00bb50″ shift_x=\u00bb0″ shift_y=\u00bb0″ shift_y_down=\u00bb0″ z_index=\u00bb0″ medium_width=\u00bb0″ mobile_width=\u00bb0″ width=\u00bb1\/3″ el_class=\u00bbpg-iclos\u00bb][vc_custom_heading heading_semantic=\u00bbh3″ text_font=\u00bbfont-195522″ text_size=\u00bbh1″ text_weight=\u00bb700″ text_color=\u00bbcolor-459661″ separator=\u00bbyes\u00bb separator_color=\u00bbyes\u00bb]Research & Development[\/vc_custom_heading][vc_column_text text_lead=\u00bbyes\u00bb css_animation=\u00bbright-t-left\u00bb animation_speed=\u00bb900″ animation_delay=\u00bb200″]The Research and Development Department of Iclos Uruguay has a Pharmaceutical Development sector and an Analytical Development sector for the development of new oncological and immunosuppressant drugs. This area allows for small-scale production, necessary for tests that make possible innovation in processes and products, and allowing to manufacture small test lots that help minimize the generation of toxic waste.[\/vc_column_text][\/vc_column_inner][vc_column_inner column_width_percent=\u00bb100″ gutter_size=\u00bb3″ back_image=\u00bb85985″ overlay_alpha=\u00bb50″ shift_x=\u00bb0″ shift_y=\u00bb0″ shift_y_down=\u00bb0″ z_index=\u00bb0″ medium_visibility=\u00bbyes\u00bb medium_width=\u00bb0″ mobile_visibility=\u00bbyes\u00bb mobile_width=\u00bb0″ width=\u00bb1\/3″ el_class=\u00bbbloque-deco\u00bb][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_inner_height_percent=\u00bb0″ force_width_grid=\u00bbyes\u00bb overlay_alpha=\u00bb50″ gutter_size=\u00bb3″ shift_y=\u00bb0″ z_index=\u00bb0″ el_class=\u00bbdestructor-total mg-iclos\u00bb][vc_column_inner column_width_percent=\u00bb100″ gutter_size=\u00bb3″ overlay_alpha=\u00bb50″ shift_x=\u00bb0″ shift_y=\u00bb0″ shift_y_down=\u00bb0″ z_index=\u00bb0″ desktop_visibility=\u00bbyes\u00bb medium_width=\u00bb0″ mobile_width=\u00bb0″ width=\u00bb1\/3″][vc_single_image media=\u00bb85986″ media_width_percent=\u00bb100″][\/vc_column_inner][vc_column_inner column_width_percent=\u00bb100″ gutter_size=\u00bb3″ overlay_alpha=\u00bb50″ shift_x=\u00bb0″ shift_y=\u00bb0″ shift_y_down=\u00bb0″ z_index=\u00bb0″ medium_width=\u00bb0″ mobile_width=\u00bb0″ width=\u00bb1\/3″ el_class=\u00bbpg-iclos\u00bb][vc_custom_heading heading_semantic=\u00bbh3″ text_font=\u00bbfont-195522″ text_size=\u00bbh1″ text_weight=\u00bb700″ text_color=\u00bbcolor-459661″ separator=\u00bbyes\u00bb separator_color=\u00bbyes\u00bb]Research & Development[\/vc_custom_heading][vc_column_text text_lead=\u00bbyes\u00bb css_animation=\u00bbright-t-left\u00bb animation_speed=\u00bb900″ animation_delay=\u00bb200″]GEMABIOTECH Research and Development Unit began its activities in 1998, and has since carried out the development, production, purification, characterization, and analysis of a wide range of recombinant products. This area is responsible for the generation of the master cell bank and the working cell bank.[\/vc_column_text][\/vc_column_inner][vc_column_inner column_width_percent=\u00bb100″ gutter_size=\u00bb3″ back_image=\u00bb85986″ overlay_alpha=\u00bb50″ shift_x=\u00bb0″ shift_y=\u00bb0″ shift_y_down=\u00bb0″ z_index=\u00bb0″ medium_visibility=\u00bbyes\u00bb medium_width=\u00bb0″ mobile_visibility=\u00bbyes\u00bb mobile_width=\u00bb0″ width=\u00bb1\/3″ el_class=\u00bbbloque-deco\u00bb][\/vc_column_inner][\/vc_row_inner][\/uncode_slider][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

[vc_row unlock_row_content=\u00bbyes\u00bb row_height_percent=\u00bb1″ override_padding=\u00bbyes\u00bb h_padding=\u00bb0″ top_padding=\u00bb0″ bottom_padding=\u00bb0″ back_color=\u00bbcolor-877404″ back_image=\u00bb84490″ back_repeat=\u00bbrepeat-y\u00bb back_position=\u00bbcenter center\u00bb overlay_alpha=\u00bb50″ equal_height=\u00bbyes\u00bb gutter_size=\u00bb0″ column_width_percent=\u00bb0″ shift_y=\u00bb0″ z_index=\u00bb0″ medium_visibility=\u00bbyes\u00bb mobile_visibility=\u00bbyes\u00bb […]<\/p>\n","protected":false},"author":7,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-85104","page","type-page","status-publish","hentry"],"yoast_head":"\nR+D - ICLOS<\/title>\n<meta name=\"description\" content=\"En Megalabs trabajamos comprometidos con nuestras comunidades de Latinoam\u00e9rica para que m\u00e1s personas puedan acceder a medicamentos de calidad superior.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/iclos.global\/eng\/research-development\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"R+D - ICLOS\" \/>\n<meta property=\"og:description\" content=\"En Megalabs trabajamos comprometidos con nuestras comunidades de Latinoam\u00e9rica para que m\u00e1s personas puedan acceder a medicamentos de calidad superior.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/iclos.global\/eng\/research-development\/\" \/>\n<meta property=\"og:site_name\" content=\"ICLOS\" \/>\n<meta property=\"article:modified_time\" content=\"2021-06-03T05:54:26+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/iclos.global\/eng\/research-development\/\",\"url\":\"https:\/\/iclos.global\/eng\/research-development\/\",\"name\":\"R+D - ICLOS\",\"isPartOf\":{\"@id\":\"https:\/\/iclos.global\/eng\/#website\"},\"datePublished\":\"2021-03-25T05:14:05+00:00\",\"dateModified\":\"2021-06-03T05:54:26+00:00\",\"description\":\"En Megalabs trabajamos comprometidos con nuestras comunidades de Latinoam\u00e9rica para que m\u00e1s personas puedan acceder a medicamentos de calidad superior.\",\"breadcrumb\":{\"@id\":\"https:\/\/iclos.global\/eng\/research-development\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/iclos.global\/eng\/research-development\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/iclos.global\/eng\/research-development\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/iclos.global\/eng\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"R+D\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/iclos.global\/eng\/#website\",\"url\":\"https:\/\/iclos.global\/eng\/\",\"name\":\"MEGALABS\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/iclos.global\/eng\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"R+D - ICLOS","description":"En Megalabs trabajamos comprometidos con nuestras comunidades de Latinoam\u00e9rica para que m\u00e1s personas puedan acceder a medicamentos de calidad superior.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/iclos.global\/eng\/research-development\/","og_locale":"es_ES","og_type":"article","og_title":"R+D - ICLOS","og_description":"En Megalabs trabajamos comprometidos con nuestras comunidades de Latinoam\u00e9rica para que m\u00e1s personas puedan acceder a medicamentos de calidad superior.","og_url":"https:\/\/iclos.global\/eng\/research-development\/","og_site_name":"ICLOS","article_modified_time":"2021-06-03T05:54:26+00:00","twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/iclos.global\/eng\/research-development\/","url":"https:\/\/iclos.global\/eng\/research-development\/","name":"R+D - ICLOS","isPartOf":{"@id":"https:\/\/iclos.global\/eng\/#website"},"datePublished":"2021-03-25T05:14:05+00:00","dateModified":"2021-06-03T05:54:26+00:00","description":"En Megalabs trabajamos comprometidos con nuestras comunidades de Latinoam\u00e9rica para que m\u00e1s personas puedan acceder a medicamentos de calidad superior.","breadcrumb":{"@id":"https:\/\/iclos.global\/eng\/research-development\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/iclos.global\/eng\/research-development\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/iclos.global\/eng\/research-development\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/iclos.global\/eng\/"},{"@type":"ListItem","position":2,"name":"R+D"}]},{"@type":"WebSite","@id":"https:\/\/iclos.global\/eng\/#website","url":"https:\/\/iclos.global\/eng\/","name":"MEGALABS","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/iclos.global\/eng\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"}]}},"_links":{"self":[{"href":"https:\/\/iclos.global\/eng\/wp-json\/wp\/v2\/pages\/85104","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/iclos.global\/eng\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/iclos.global\/eng\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/iclos.global\/eng\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/iclos.global\/eng\/wp-json\/wp\/v2\/comments?post=85104"}],"version-history":[{"count":0,"href":"https:\/\/iclos.global\/eng\/wp-json\/wp\/v2\/pages\/85104\/revisions"}],"wp:attachment":[{"href":"https:\/\/iclos.global\/eng\/wp-json\/wp\/v2\/media?parent=85104"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}